DoseSpot - Comprehensive Analysis Report

Summary

DoseSpot is a certified ePrescribing platform founded in 2009 and based in Dedham, Massachusetts. The company's mission is to enhance the healthcare experience through innovation, allowing prescribers to focus more on patient care. DoseSpot achieves this by streamlining the prescription process and integrating with electronic health records (EHRs), electronic dental records, practice management, and telehealth software. In March 2026, DoseSpot merged with Arrive Health to form Interra Health, a strategic move aimed at unifying the journey from medical and pharmacy benefits to prescription fulfillment and advancing real-time medication price transparency for providers and patients. The combined entity is projected to exceed $100 million in revenue in 2026 and is profitable, growing at approximately 40% annually.

1. Strategic Focus & Objectives

Core Objectives

DoseSpot's strategic focus is delivering an all-in-one, patient-centric ePrescribing solution that optimizes efficiency, ensures compliance, and empowers patients through price transparency and pharmacy choice. Key objectives include:

• Streamlining prescription workflows and reducing administrative burdens for healthcare providers.

• Enhancing patient safety by minimizing medication errors and improving medication adherence.

• Ensuring strict adherence to federal and state regulations, including those governing controlled substances (EPCS).

• Integrating novel solutions for price transparency, prescription savings, and benefits management to future-proof healthcare systems.

Specialization Areas

DoseSpot specializes in deep integration capabilities, offering over 140-250 APIs for extensive workflow customization and seamless interoperability. This allows for rapid deployment, with their Jumpstart integration going live in 30 days and Full Integration in 3-6 months. The platform supports diverse healthcare systems including telehealth, health systems, and dental practices. The company's core value proposition lies in its superior performance and speed, claiming less than 300 milliseconds response times, which is up to five times faster than other e-prescribing products.

Target Markets

DoseSpot primarily targets healthcare providers, including medical, dental, and telehealth organizations, seeking to enhance their ePrescribing capabilities. Their solutions cater to practices of various sizes by offering customizable integrations with existing electronic health records (EHRs), electronic dental records, and practice management software.

2. Financial Overview

Funding History

DoseSpot secured a Seed funding round on January 27, 2022, from PSG, a growth equity firm. The total amount raised in this round was undisclosed. PSG's investment aimed to accelerate DoseSpot's ability to support existing and new customers and expand its user base. As of March 2026, the company, combined with Arrive Health to form Interra Health, is projected to exceed $100 million in revenue in 2026 and is profitable, growing at approximately 40% annually.

3. Product Pipeline

Key Products/Services

DoseSpot offers a comprehensive suite of ePrescribing solutions:

• Core ePrescribing: This foundational offering provides a complete platform for electronically writing and transmitting prescriptions, including controlled substances (EPCS), to pharmacies safely and efficiently. It features a deep dive into patient details and fosters data-driven decision-making.

• Development Stage: Fully operational and Surescripts-certified.

• Target Market/Condition: Healthcare providers in all care settings, including medical and dental practices, and telehealth platforms.

• Expected Timeline: Immediately available.

• Key Features and Benefits: Reduces prescription errors, improves efficiency, facilitates immediate delivery of prescriptions, especially important for telehealth.

• DoseSpot Connect: This patient engagement tool empowers patients to find affordable medications and schedule pick-ups at their preferred pharmacies.

• Development Stage: Fully operational.

• Target Market/Condition: Patients to improve medication adherence and engagement.

• Expected Timeline: Immediately available.

• Key Features and Benefits: Provides medication cost transparency and choice of affordable medications, improving patient engagement and adherence.

• Electronic Prior Authorization (ePA): This tool streamlines the prior authorization process, providing real-time capabilities and integrating with major networks to reduce treatment delays.

• Development Stage: Fully operational and integrated with networks like CoverMyMeds and Surescripts.

• Target Market/Condition: Healthcare providers and patients to expedite approval for prescribed medications, reducing administrative burden and treatment delays.

• Expected Timeline: Immediately available.

• Key Features and Benefits: Automates the PA process, facilitating faster approvals and ensuring clear prior authorization requirements.

• Real-Time Prescription Benefit (RTPB): This feature reveals covered medication costs and alternatives at the point of care, significantly impacting medication adherence.

• Development Stage: Fully operational.

• Target Market/Condition: Prescribers and patients to address medication affordability and improve adherence.

• Expected Timeline: Immediately available.

• Key Features and Benefits: Provides real-time drug costs, helping prescribers and patients choose affordable medications and improve adherence.

4. Technology & Innovation

Technology Stack

DoseSpot's technology platform is a cloud-based, Surescripts-certified and Drummond Group-certified ePrescribing solution. This ensures full compliance with NCPDP standards and all federal and state regulations, including those for controlled substances (EPCS). The platform is accessible from anywhere on any device.

Proprietary Developments

DoseSpot's proprietary technologies include:

• Comprehensive API Integration: Offering over 140-250 APIs for extensive customization of ePrescribing workflows, allowing for seamless interoperability with telehealth, health systems, and dental practices.

• DoseSpot Connect: A patient engagement tool designed to enhance medication adherence by empowering patients with pharmacy choice and medication cost information.

• Electronic Prior Authorization (ePA) and Real-Time Prescription Benefit (RTPB) tools: These features provide real-time drug costs, facilitate faster approvals, and enable patients to choose affordable medications.

Scientific Methodologies

DoseSpot incorporates several mechanisms to enhance patient safety and clinical decision-making:

• Drug-drug and drug-allergy interaction alerts: These alerts notify prescribers of potential conflicts at the point of care.

• Formulary information: Provides prescribers with access to up-to-date medication formulary data.

• Narx scores: Integrates with state Prescription Drug Monitoring Programs (PDMPs) to provide real-time data on patient prescription histories, aiding in the identification of potential misuse of controlled substances.

• Dynamic queueing mechanism: Developed by the technical team to efficiently direct requests for Real-Time Prescription Benefit data across various data provider networks, ensuring a diversified and reliable platform.

Technical Capabilities

DoseSpot's platform boasts significant technical capabilities:

• Surescripts and Drummond Group certifications: Ensures compliance with industry standards and regulations for e-prescribing.

• EPCS certification: Allows for the secure electronic prescribing of controlled substances.

• Extensive API library: Facilitates deep integration with over 220 successful integrations and a wide range of healthcare systems.

• Cloud-based architecture: Provides high accessibility and scalability.

• Rapid response times: Achieves application response times less than 300 milliseconds.

5. Leadership & Management

Executive Team

• Josh Weiner, Chief Executive Officer: Josh Weiner has a proven track record in scaling software companies, with extensive experience in healthcare technology. He previously served as CEO of Solutionreach, a healthcare SaaS patient engagement firm, and was an operating partner at Summit Partners for six years. His career began as a consultant with McKinsey & Company.

• Tosin Adesegha, Chief Financial Officer: Tosin Adesegha is responsible for the financial strategy and operations of the company.

• Michelle Kohut, Chief Technology Officer: Michelle Kohut has over ten years of experience at DoseSpot, leading software development and engineering teams. She has been instrumental in the company's growth, including developing the Real-Time Prescription Benefit feature.

• Julian Herbert, Chief Product Officer: Julian Herbert focuses on revolutionizing e-prescribing by prioritizing patient safety, efficiency, and empowerment.

• Adam Gail, Chief Revenue Officer: Adam Gail leads the company's revenue generation strategies and sales efforts.

Recent Leadership Changes

In March 2026, following the merger of DoseSpot and Arrive Health to form Interra Health, Josh Weiner, former CEO of DoseSpot, assumed the role of CEO and a board member of the newly combined company. Kyle Kiser, former CEO of Arrive Health, became a board member and senior advisor for Interra Health.

6. Talent and Growth Indicators

Hiring Trends and Workforce

DoseSpot, now operating under Interra Health, is on a hyper-growth trajectory within the software and healthcare industries. The company emphasizes a "Promote from within" philosophy and encourages employees to "Grow Your Career with DoseSpot!". They offer job training and conferences with a focus on training and mentoring. Recent job postings indicate a diverse range of roles being recruited, primarily remote, including:

• Product Manager (Remote, Boston)

• Corporate Counsel (Remote, Boston)

• Implementation Specialist (Remote, Boston)

• Staff Software Engineer (Remote, Boston)

• Enterprise Account Executive (Remote, Boston)

• Senior DevOps Engineer (Remote, India)

• Revenue Analytics & Partner Success Manager (Remote, Boston)

• Software Developer (Remote, India)

• Java Developer - Team Lead (Remote, Boston)

• Business Development Representatives (Remote, Boston)

• Remote Pharma Sales Executive - Strategic Growth (Boston)

Company Growth Trajectory Indicators

As of October 2025, DoseSpot served over 300 healthcare clients and supported more than 200,000 registered users monthly. The acquisition of pVerify in April 2025 and TreatRx in March 2023 signify strategic growth through expansion of its offerings. The merger with Arrive Health to form Interra Health has significantly scaled the company's reach, now serving 800,000 providers and handling 50 million prescriptions annually via DoseSpot's technology.

Employee Sentiment and Culture Insights

While specific Glassdoor sentiment analysis is not explicitly available, company career materials highlight a growth-oriented culture that values accountability, collaboration, and curiosity. The environment is described as remote-first, flexible, and collaborative. However, there have been some observations of potential challenges regarding inconsistent advancement, unclear progression pathways, and knowledge silos, which may impact learning and development in certain areas.

Company Size and Expansion Metrics

DoseSpot reported 85 employees as of October 2025 and 25 employees as of July 2024. With the recent merger and ambitious revenue projections for Interra Health, the company is demonstrating substantial growth and expansion.

7. Social Media Presence and Engagement

Digital Footprint

DoseSpot maintains an active social media presence across various platforms, sharing company news, thought leadership, and industry insights. Their blog serves as a resource for updates on ePrescribing software, integrations, and broader healthcare technology trends.

Brand Messaging and Positioning

Key messaging revolves around innovation in e-prescribing, patient empowerment through real-time prescription price transparency, compliance expertise, and seamless integration capabilities.

Community Engagement Strategies

DoseSpot's engagement strategies often highlight new strategic collaborations and participate in discussions surrounding evolving healthcare regulations.

Notable Campaigns or Content

The company's social media content frequently focuses on the benefits of e-prescribing, such as improving accuracy and safety, enhancing efficiency, and providing better tracking of prescribing behavior.

8. Recognition and Awards

Industry Recognition

In January 2026, DoseSpot's subsidiary, pVerify, received multiple 2025 recognitions from Gartner Digital Markets' Capterra, Software Advice, and GetApp.

9. Competitive Analysis

Major Competitors

DoseSpot operates within a competitive e-prescribing and healthcare IT market. Key competitors include:

• TherapyNotes: Focuses on practice management for behavioral health.

• AdvancedMD: Offers a comprehensive cloud-based healthcare management solution that integrates practice management, electronic health records, medical billing, and patient engagement tools.

• Practice Fusion: A cloud-based EHR platform designed for independent medical practices, streamlining clinical workflows, offering customizable templates, e-prescribing, and patient engagement tools.

• RXNT: An ambulatory healthcare technology pioneer providing a fully-integrated, ONC-certified suite of medical software including Clinical EHRs, Practice Management, Medical Billing, RCM, E-Prescribing, and Patient Portals.

• Surescripts: A major network for electronic prescription routing, with whom DoseSpot is certified.

• EazyScripts: Aims to simplify the transition to e-prescribing and helps patients discover prescription cost savings.

• DrFirst: E-prescribing software that helps physicians generate diagnose-specific prescriptions, manage patients, and perform drug benefit checks.

• MDToolbox-Rx: A certified, award-winning electronic prescription writer that can run standalone or synced with other office software, offering e-prescribing, eligibility, formulary, EPCS, and electronic prior authorization.

• CoverMyMeds: A healthcare technology platform dedicated to improving medication access by streamlining the prior authorization process.

10. Market Analysis

Market Overview

The e-prescribing market is a dynamic and essential component of modern healthcare delivery. Its growth is primarily driven by the imperative to enhance accuracy, improve efficiency, and ensure regulatory compliance in medication management.

Growth Potential

The market demonstrates significant growth potential, with 92% of prescribers now utilizing electronic prescribing, an 85% increase since 2008. This expansion reflects a recognition that modern patient care demands efficient, secure, and integrated digital technology.

Key Market Trends

• Demand for Real-Time Prescription Benefits and Electronic Prior Authorization: These features are increasingly crucial for addressing patient affordability concerns and mitigating treatment delays.

• Seamless Integration with Existing EHR/EMR Systems: The ability to integrate effortlessly with existing electronic health records and electronic medical record systems is a key differentiator.

• Support for Telehealth and Digital Health Platforms: As telehealth services expand, e-prescribing solutions must seamlessly support these platforms.

• Secure Electronic Transmission of Controlled Substances: There is a strong emphasis on secure EPCS, supported by integrations with Prescription Drug Monitoring Programs (PDMPs).

Market Challenges and Opportunities

Challenges:

• Integration complexities: Although integrations are becoming easier, some healthcare organizations still face challenges in integrating new e-prescribing solutions with their legacy systems.

• User adoption: Ensuring all prescribers adopt new e-prescribing technologies can be a hurdle.

• Evolving regulations: The landscape of federal and state regulations, especially concerning controlled substances and telehealth prescribing, requires continuous adaptation.

Opportunities:

• Patient empowerment: Solutions that offer price transparency and pharmacy choice enhance patient engagement and adherence.

• Reduced medication errors: E-prescribing significantly reduces errors associated with handwritten prescriptions.

• Operational efficiency: Streamlining the prescription workflow saves time for providers and patients.

• Data-driven decision making: E-prescribing platforms provide valuable data for performance insights and improved care.

11. Strategic Partnerships

• PSG (Growth Equity Firm): Received a growth investment from PSG in January 2022 to accelerate customer support and user base expansion.

• pVerify: Acquired in April 2025, pVerify provides real-time healthcare APIs for eligibility, insurance discovery, instant prior authorization, and estimation, enhancing DoseSpot's revenue cycle management offerings. Both companies operate independently, identifying cross-collaboration points.

• TreatRx: Acquired ePrescribing platform TreatRx in March 2023, offering a standalone EPCS-certified e-prescribing solution for smaller practices or those without an EMR/EHR.

• Amazon Pharmacy: Collaborated in July 2025 to improve prescription medication pricing transparency, expand medication access, and offer faster delivery options for DoseSpot users.

• Arrive Health: Merged with Arrive Health in March 2026 to form Interra Health. This merger combines DoseSpot's e-prescribing with Arrive Health's coverage and pricing network to provide real-time medication price transparency and access insights. Bain Capital Tech Opportunities is the majority owner of Interra Health, with PSG, Providence, and UPMC Enterprises as minority investors.

• Lightning Step: Collaborated with Lightning Step to help behavioral health organizations manage prescriptions.

12. Operational Insights

DoseSpot's operational strategy centers on providing a highly customizable and integratable e-prescribing platform. Its key differentiators include exceptional speed, with application response times 80% faster than industry incumbents, and extensive API offerings (140-250 APIs) that enable partners to seamlessly tailor solutions into their existing workflows. The company prioritizes adherence to compliance standards, holding certifications from Surescripts and Drummond Group, including EPCS, ensuring its platform meets rigorous industry standards. [cite# DoseSpot - Comprehensive Analysis Report

Summary

DoseSpot is a certified ePrescribing platform founded in 2009 and based in Dedham, Massachusetts. The company's mission is to enhance the healthcare experience through innovation, allowing prescribers to focus more on patient care. DoseSpot achieves this by streamlining the prescription process and integrating with electronic health records (EHRs), electronic dental records, practice management, and telehealth software. In March 2026, DoseSpot merged with Arrive Health to form Interra Health, a strategic move aimed at unifying the journey from medical and pharmacy benefits to prescription fulfillment and advancing real-time medication price transparency for providers and patients. The combined entity is projected to exceed $100 million in revenue in 2026 and is profitable, growing at approximately 40% annually.

1. Strategic Focus & Objectives

Core Objectives

DoseSpot's strategic focus is delivering an all-in-one, patient-centric ePrescribing solution that optimizes efficiency, ensures compliance, and empowers patients through price transparency and pharmacy choice. Key objectives include:

• Streamlining prescription workflows and reducing administrative burdens for healthcare providers.

• Enhancing patient safety by minimizing medication errors and improving medication adherence.

• Ensuring strict adherence to federal and state regulations, including those governing controlled substances (EPCS).

• Integrating novel solutions for price transparency, prescription savings, and benefits management to future-proof healthcare systems.

Specialization Areas

DoseSpot specializes in deep integration capabilities, offering over 140-250 APIs for extensive workflow customization and seamless interoperability. This allows for rapid deployment, with their Jumpstart integration going live in 30 days and Full Integration in 3-6 months. The platform supports diverse healthcare systems including telehealth, health systems, and dental practices. The company's core value proposition lies in its superior performance and speed, claiming less than 300 milliseconds response times, which is up to five times faster than other e-prescribing products. [cite: 5]

Target Markets

DoseSpot primarily targets healthcare providers, including medical, dental, and telehealth organizations, seeking to enhance their ePrescribing capabilities. Their solutions cater to practices of various sizes by offering customizable integrations with existing electronic health records (EHRs), electronic dental records, and practice management software.

2. Financial Overview

Funding History

DoseSpot secured a Seed funding round on January 27, 2022, from PSG, a growth equity firm. The total amount raised in this round was undisclosed. PSG's investment aimed to accelerate DoseSpot's ability to support existing and new customers and expand its user base. As of March 2026, the company, combined with Arrive Health to form Interra Health, is projected to exceed $100 million in revenue in 2026 and is profitable, growing at approximately 40% annually.

3. Product Pipeline

Key Products/Services

DoseSpot offers a comprehensive suite of ePrescribing solutions:

• Core ePrescribing: This foundational offering provides a complete platform for electronically writing and transmitting prescriptions, including controlled substances (EPCS), to pharmacies safely and efficiently. [cite: 3, 5] It features a deep dive into patient details and fosters data-driven decision-making. [cite: 5]

• Development Stage: Fully operational and Surescripts-certified. [cite: 3]

• Target Market/Condition: Healthcare providers in all care settings, including medical and dental practices, and telehealth platforms. [cite: 11]

• Expected Timeline: Immediately available.

• Key Features and Benefits: Reduces prescription errors, improves efficiency, facilitates immediate delivery of prescriptions, especially important for telehealth. [cite: 8, 11]

• DoseSpot Connect: This patient engagement tool empowers patients to find affordable medications and schedule pick-ups at their preferred pharmacies. [cite: 5]

• Development Stage: Fully operational.

• Target Market/Condition: Patients to improve medication adherence and engagement. [cite: 5]

• Expected Timeline: Immediately available.

• Key Features and Benefits: Provides medication cost transparency and choice of affordable medications, improving patient engagement and adherence. [cite: 5]

• Electronic Prior Authorization (ePA): This tool streamlines the prior authorization process, providing real-time capabilities and integrating with major networks to reduce treatment delays. [cite: 5]

• Development Stage: Fully operational and integrated with networks like CoverMyMeds and Surescripts. [cite: 9]

• Target Market/Condition: Healthcare providers and patients to expedite approval for prescribed medications, reducing administrative burden and treatment delays. [cite: 5]

• Expected Timeline: Immediately available.

• Key Features and Benefits: Automates the PA process, facilitating faster approvals and ensuring clear prior authorization requirements. [cite: 5]

• Real-Time Prescription Benefit (RTPB): This feature reveals covered medication costs and alternatives at the point of care, significantly impacting medication adherence. [cite: 5]

• Development Stage: Fully operational.

• Target Market/Condition: Prescribers and patients to address medication affordability and improve adherence. [cite: 5]

• Expected Timeline: Immediately available.

• Key Features and Benefits: Provides real-time drug costs, helping prescribers and patients choose affordable medications and improve adherence. [cite: 5]

4. Technology & Innovation

Technology Stack

DoseSpot's technology platform is a cloud-based, Surescripts-certified and Drummond Group-certified ePrescribing solution. [cite: 3] This ensures full compliance with NCPDP standards and all federal and state regulations, including those for controlled substances (EPCS). [cite: 3] The platform is accessible from anywhere on any device.

Proprietary Developments

DoseSpot's proprietary technologies include:

• Comprehensive API Integration: Offering over 140-250 APIs for extensive customization of ePrescribing workflows, allowing for seamless interoperability with telehealth, health systems, and dental practices.

• DoseSpot Connect: A patient engagement tool designed to enhance medication adherence by empowering patients with pharmacy choice and medication cost information. [cite: 5]

• Electronic Prior Authorization (ePA) and Real-Time Prescription Benefit (RTPB) tools: These features provide real-time drug costs, facilitate faster approvals, and enable patients to choose affordable medications. [cite: 5]

Scientific Methodologies

DoseSpot incorporates several mechanisms to enhance patient safety and clinical decision-making:

• Drug-drug and drug-allergy interaction alerts: These alerts notify prescribers of potential conflicts at the point of care.

• Formulary information: Provides prescribers with access to up-to-date medication formulary data.

• Narx scores: Integrates with state Prescription Drug Monitoring Programs (PDMPs) to provide real-time data on patient prescription histories, aiding in the identification of potential misuse of controlled substances.

• Dynamic queueing mechanism: Developed by the technical team to efficiently direct requests for Real-Time Prescription Benefit data across various data provider networks, ensuring a diversified and reliable platform.

Technical Capabilities

DoseSpot's platform boasts significant technical capabilities:

• Surescripts and Drummond Group certifications: Ensures compliance with industry standards and regulations for e-prescribing. [cite: 3]

• EPCS certification: Allows for the secure electronic prescribing of controlled substances. [cite: 3]

• Extensive API library: Facilitates deep integration with over 220 successful integrations and a wide range of healthcare systems. [cite: 13]

• Cloud-based architecture: Provides high accessibility and scalability.

• Rapid response times: Achieves application response times less than 300 milliseconds.

5. Leadership & Management

Executive Team

• Josh Weiner, Chief Executive Officer: Josh Weiner has a proven track record in scaling software companies, with extensive experience in healthcare technology. He previously served as CEO of Solutionreach, a healthcare SaaS patient engagement firm, and was an operating partner at Summit Partners for six years. His career began as a consultant with McKinsey & Company.

• Tosin Adesegha, Chief Financial Officer: Tosin Adesegha is responsible for the financial strategy and operations of the company.

• Michelle Kohut, Chief Technology Officer: Michelle Kohut has over ten years of experience at DoseSpot, leading software development and engineering teams. She has been instrumental in the company's growth, including developing the Real-Time Prescription Benefit feature.

• Julian Herbert, Chief Product Officer: Julian Herbert focuses on revolutionizing e-prescribing by prioritizing patient safety, efficiency, and empowerment.

• Adam Gail, Chief Revenue Officer: Adam Gail leads the company's revenue generation strategies and sales efforts.

Recent Leadership Changes

In March 2026, following the merger of DoseSpot and Arrive Health to form Interra Health, Josh Weiner, former CEO of DoseSpot, assumed the role of CEO and a board member of the newly combined company. Kyle Kiser, former CEO of Arrive Health, became a board member and senior advisor for Interra Health.

6. Talent and Growth Indicators

Hiring Trends and Workforce

DoseSpot, now operating under Interra Health, is on a hyper-growth trajectory within the software and healthcare industries. The company emphasizes a "Promote from within" philosophy and encourages employees to "Grow Your Career with DoseSpot!". They offer job training and conferences with a focus on training and mentoring. Recent job postings indicate a diverse range of roles being recruited, primarily remote, including:

• Product Manager (Remote, Boston)

• Corporate Counsel (Remote, Boston)

• Implementation Specialist (Remote, Boston)

• Staff Software Engineer (Remote, Boston)

• Enterprise Account Executive (Remote, Boston)

• Senior DevOps Engineer (Remote, India)

• Revenue Analytics & Partner Success Manager (Remote, Boston)

• Software Developer (Remote, India)

• Java Developer - Team Lead (Remote, Boston)

• Business Development Representatives (Remote, Boston)

• Remote Pharma Sales Executive - Strategic Growth (Boston)

Company Growth Trajectory Indicators

As of October 2025, DoseSpot served over 300 healthcare clients and supported more than 200,000 registered users monthly. The acquisition of pVerify in April 2025 and TreatRx in March 2023 signify strategic growth through expansion of its offerings. The merger with Arrive Health to form Interra Health has significantly scaled the company's reach, now serving 800,000 providers and handling 50 million prescriptions annually via DoseSpot's technology. [cite: 5]

Employee Sentiment and Culture Insights

While specific Glassdoor sentiment analysis is not explicitly available, company career materials highlight a growth-oriented culture that values accountability, collaboration, and curiosity. The environment is described as remote-first, flexible, and collaborative. However, there have been some observations of potential challenges regarding inconsistent advancement, unclear progression pathways, and knowledge silos, which may impact learning and development in certain areas.

Company Size and Expansion Metrics

DoseSpot reported 85 employees as of October 2025 and 25 employees as of July 2024. [cite: 13] With the recent merger and ambitious revenue projections for Interra Health, the company is demonstrating substantial growth and expansion.

7. Social Media Presence and Engagement

Digital Footprint

DoseSpot maintains an active social media presence across various platforms, sharing company news, thought leadership, and industry insights. Their blog serves as a resource for updates on ePrescribing software, integrations, and broader healthcare technology trends. [cite: 6]

Brand Messaging and Positioning

Key messaging revolves around innovation in e-prescribing, patient empowerment through real-time prescription price transparency, compliance expertise, and seamless integration capabilities. [cite: 6]

Community Engagement Strategies

DoseSpot's engagement strategies often highlight new strategic collaborations and participate in discussions surrounding evolving healthcare regulations.

Notable Campaigns or Content

The company's social media content frequently focuses on the benefits of e-prescribing, such as improving accuracy and safety, enhancing efficiency, and providing better tracking of prescribing behavior. [cite: 8, 9]

8. Recognition and Awards

Industry Recognition

In January 2026, DoseSpot's subsidiary, pVerify, received multiple 2025 recognitions from Gartner Digital Markets' Capterra, Software Advice, and GetApp.

9. Competitive Analysis

Major Competitors

DoseSpot operates within a competitive e-prescribing and healthcare IT market. Key competitors include:

• TherapyNotes: Focuses on practice management for behavioral health. [cite: 2]

• AdvancedMD: Offers a comprehensive cloud-based healthcare management solution that integrates practice management, electronic health records, medical billing, and patient engagement tools. [cite: 2]

• Practice Fusion: A cloud-based EHR platform designed for independent medical practices, streamlining clinical workflows, offering customizable templates, e-prescribing, and patient engagement tools. [cite: 2, 18]

• RXNT: An ambulatory healthcare technology pioneer providing a fully-integrated, ONC-certified suite of medical software including Clinical EHRs, Practice Management, Medical Billing, RCM, E-Prescribing, and Patient Portals. [cite: 4, 7]

• Surescripts: A major network for electronic prescription routing, with whom DoseSpot is certified. [cite: 3]

• EazyScripts: Aims to simplify the transition to e-prescribing and helps patients discover prescription cost savings. [cite: 4]

• DrFirst: E-prescribing software that helps physicians generate diagnose-specific prescriptions, manage patients, and perform drug benefit checks. [cite: 12]

• MDToolbox-Rx: A certified, award-winning electronic prescription writer that can run standalone or synced with other office software, offering e-prescribing, eligibility, formulary, EPCS, and electronic prior authorization. [cite: 4]

• CoverMyMeds: A healthcare technology platform dedicated to improving medication access by streamlining the prior authorization process. [cite: 2]

10. Market Analysis

Market Overview

The e-prescribing market is a dynamic and essential component of modern healthcare delivery. Its growth is primarily driven by the imperative to enhance accuracy, improve efficiency, and ensure regulatory compliance in medication management. [cite: 8]

Growth Potential

The market demonstrates significant growth potential, with 92% of prescribers now utilizing electronic prescribing, an 85% increase since 2008. [cite: 7] This expansion reflects a recognition that modern patient care demands efficient, secure, and integrated digital technology. [cite: 7]

Key Market Trends

• Demand for Real-Time Prescription Benefits and Electronic Prior Authorization: These features are increasingly crucial for addressing patient affordability concerns and mitigating treatment delays. [cite: 5, 9]

• Seamless Integration with Existing EHR/EMR Systems: The ability to integrate effortlessly with existing electronic health records and electronic medical record systems is a key differentiator. [cite: 9]

• Support for Telehealth and Digital Health Platforms: As telehealth services expand, e-prescribing solutions must seamlessly support these platforms. [cite: 11]

• Secure Electronic Transmission of Controlled Substances: There is a strong emphasis on secure EPCS, supported by integrations with Prescription Drug Monitoring Programs (PDMPs). [cite: 9]

Market Challenges and Opportunities

Challenges:

• Integration complexities: Although integrations are becoming easier, some healthcare organizations still face challenges in integrating new e-prescribing solutions with their legacy systems. [cite: 9]

• User adoption: Ensuring all prescribers adopt new e-prescribing technologies can be a hurdle. [cite: 7]

• Evolving regulations: The landscape of federal and state regulations, especially concerning controlled substances and telehealth prescribing, requires continuous adaptation.

Opportunities:

• Patient empowerment: Solutions that offer price transparency and pharmacy choice enhance patient engagement and adherence. [cite: 5]

• Reduced medication errors: E-prescribing significantly reduces errors associated with handwritten prescriptions. [cite: 8]

• Operational efficiency: Streamlining the prescription workflow saves time for providers and patients. [cite: 8]

• Data-driven decision making: E-prescribing platforms provide valuable data for performance insights and improved care. [cite: 5]

11. Strategic Partnerships

• PSG (Growth Equity Firm): Received a growth investment from PSG in January 2022 to accelerate customer support and user base expansion.

• pVerify: Acquired in April 2025, pVerify provides real-time healthcare APIs for eligibility, insurance discovery, instant prior authorization, and estimation, enhancing DoseSpot's revenue cycle management offerings. Both companies operate independently, identifying cross-collaboration points.

• TreatRx: Acquired ePrescribing platform TreatRx in March 2023, offering a standalone EPCS-certified e-prescribing solution for smaller practices or those without an EMR/EHR.

• Amazon Pharmacy: Collaborated in July 2025 to improve prescription medication pricing transparency, expand medication access, and offer faster delivery options for DoseSpot users.

• Arrive Health: Merged with Arrive Health in March 2026 to form Interra Health. This merger combines DoseSpot's e-prescribing with Arrive Health's coverage and pricing network to provide real-time medication price transparency and access insights. Bain Capital Tech Opportunities is the majority owner of Interra Health, with PSG, Providence, and UPMC Enterprises as minority investors.

• Lightning Step: Collaborated with Lightning Step to help behavioral health organizations manage prescriptions.

12. Operational Insights

DoseSpot's operational strategy centers on providing a highly customizable and integratable e-prescribing platform. Its key differentiators include exceptional speed, with application response times 80% faster than industry incumbents, and extensive API offerings (140-250 APIs) that enable partners to seamlessly tailor solutions into their existing workflows. The company prioritizes adherence to compliance standards, holding certifications from Surescripts and Drummond Group, including EPCS, ensuring its platform meets rigorous industry standards. [cite